Biotech stocks are undoubtedly one of the most volatile group of equities in the market today. While extreme volatility can be hard to stomach, the wild price swings associated with small- to mid-cap biotech stocks can also create stellar buying opportunities for investors with a long-term outlook.
The rare-disease drugmakers BioMarin Pharmaceutical (NASDAQ:BMRN) and Sarepta Therapeutics (NASDAQ:SRPT) are two prime examples. Both of these mid-caps have seen their share prices take a big hit over the last 52 weeks. But… Continue reading at Fool.com